Elsevier

Clinical Biochemistry

Volume 50, Issue 18, December 2017, Pages 1306-1311
Clinical Biochemistry

Review
The investigation of interferences in immunoassay

https://doi.org/10.1016/j.clinbiochem.2017.08.015Get rights and content

Highlights

  • Procedures for investigation of unusual or unexpected immunoassay results

  • Practical approach based on personal experiences for routine non-specialised laboratories

  • Summary of common interferences

Abstract

Immunoassay procedures have a wide application in clinical medicine and as such are used throughout clinical biochemistry laboratories both for urgent and routine testing. Clinicians and laboratory personnel are often presented with immunoassay results which are inconsistent with clinical findings. Without a high index of suspicion interferences will often not be suspected. Artifactual results can be due to a range of interferences in immunoassays which can include cross reacting substances, heterophile antibodies, autoantibodies and the high dose hook effect. Further, pre-analytical aspects and certain disease states can influence the potential for interference in immunoassays. Practical solutions for investigation of artifactual results in the setting of the routine clinical laboratory are provided.

Introduction

Most clinicians accept laboratory results at face value and do not query the validity of that result. For this reason the laboratory has a particular responsibility to ensure the validity of the results they release.

Immunoassay is an important part of the diagnostic pathology laboratory, and because of the relatively low concentrations of analyte being measured and because of the complexities of the antigen-antibody interaction, this technique is relatively susceptible to interferences.

In some areas, possible interferences may be highly problematic and highly visible. A good example is with the use of troponin in assessing the person with possible acute coronary syndrome. The presence of troponin is a core part of the diagnosis of myocardial infarction and results are frequently required urgently. We have had patients present with a relatively constant concentration of troponin regardless of whether they are experiencing chest pain, suggesting that the apparent troponin result is artifactual. With such patients it is of considerable importance to sort out what is happening – is an interferent present or is the troponin result real?

However, with many assays there may never be reason to suspect the presence of an interferent as the results may be open to interpretations that can handle a variety of results. An example of this is serology looking at possible infections, where either a negative or a positive result can be rationalised on clinical grounds.

The purpose of this review is not so much to identify the mechanisms of immunoassay interferences – there have been many excellent reviews published on this topic [1], [2], [3], [4], [5], [6], [7], [8] – but rather to discuss ways of becoming aware of possible interferences and how to investigate them. We have deliberately concentrated on relatively simple procedures that will be available in non-specialist laboratories.

Section snippets

The nature of interferences

An interference is defined as the effect of a substance present in the sample that alters the correct value of the result [9]. There are many possible reasons for false results to be obtained during an immunoassay procedure and these are considered briefly below.

Interferences in immunoassay fall in to 2 broad categories – analyte-independent and analyte-dependent, as shown in Table 1. Analyte-independent problems are considered below in the section on the investigation of possible

Clues as to the presence of a possible interference

There are 2 usual ways in which the possibility of an interferent may be suspected.

The investigation of possible interferences

A proposed sequence of investigations of possible interferences is shown in Table 3 and expanded below.

Conclusions

Immunoassay is no place for optimists. Interferences can and do occur and they will not be identified unless analysts are alert and suspicious regarding the results they put out.

While tools such as heterophile blocking tubes are widely believed to be all the investigation that is needed for possible interferences, as indicated in the text above, it appears that they do not work reliably in assays using murine antibodies and these are the commonest antibodies used in immunoassay laboratories.

It

Conflicts of interest

None.

Funding

This research did not receive any specific grant from funding agencies in the public, commercial or not-for-profit sectors.

References (63)

  • L.J. Kricka

    Human anti-animal antibody interferences in immunological assays

    Clin. Chem.

    (1999)
  • C. Selby

    Interference in immunoassay

    Ann. Clin. Biochem.

    (1999)
  • J. Tate et al.

    Interferences in immunoassay

    Clin. Biochem. Rev.

    (2004)
  • C.M. Sturgeon et al.

    Analytical error and interference in immunoassay: minimizing risk

    Ann. Clin. Biochem.

    (2011)
  • A.A.A. Ismail

    Idenitfying and reducing potentially wrong immunoassay results even when plausible and “not unreasonable”

    Adv. Clin. Chem.

    (2016)
  • M.H. Kroll et al.

    Interference with clinical laboratory analyses

    Clin. Chem.

    (1994)
  • A.J. Dodd et al.

    The effect of serum matrix and gender on cortisol measurement by commonly used immunoassays

    Ann. Clin. Biochem.

    (2014)
  • D.J. Andrews et al.

    Cyclosporin: revision in monitoring guidelines and review of current analytical methods

    Ann. Clin. Biochem.

    (2002)
  • M.N. Fahie-Wilson et al.

    Macroprolactin; high molecular mass forms of circulating prolactin

    Ann. Clin. Biochem.

    (2005)
  • D. Sinclair

    Clinical and laboratory aspects of thyroid autoantibodies

    Ann. Clin. Biochem.

    (2006)
  • A.T. Remaley et al.

    Macroenzymes: biochemical characterization, clinical significance, and laboratory detection

    Clin. Chem.

    (1989)
  • H. Sakai et al.

    Falsely elevated thyroid-stimulating hormone (TSH) level due to macro-TSH

    Endocr. J.

    (2009)
  • C.A. Spencer

    Clinical review: clinical utility of thyroglobulin antibody (TgAb) measurements for patients with differentiated thyroid cancers (DTC)

    J. Clin. Endocrinol. Metab.

    (2011)
  • S. Sakata et al.

    Prevalence of thyroid hormone autoantibodies in healthy subjects

    Clin. Endocrinol.

    (1994)
  • P.A. Torjesen et al.

    Antibodies against [125I] testosterone in patient's serum: a problem for the laboratory and the patient

    Clin. Chem.

    (1996)
  • A. Kuwahara et al.

    Autoantibody against testosterone in a woman with hypergonadotropic hypogonadism

    J. Clin. Endocrinol. Metab.

    (1998)
  • R. Mierau et al.

    Diagnosis and prognosis of early rheumatoid arthritis, with special emphasis on laboratory analysis

    Clin. Chem. Lab. Med.

    (2006)
  • A. Dasgupta et al.

    False-positive troponin I in the MEIA due to the presence of rheumatoid factors in serum

    Am. J. Clin. Pathol.

    (1999)
  • N. Despres et al.

    Antibody interference in thyroid assays: a potential for clinical misinformation

    Clin. Chem.

    (1998)
  • J. Gibney et al.

    Clinical relevance of macroprolactin

    Clin. Endocrinol.

    (2005)
  • G. Lindstedt

    Endogenous antibodies against prolactin – a “new” cause of hyperprolactinaemia

    Eur. J. Endocrinol.

    (1994)
  • Cited by (95)

    View all citing articles on Scopus
    View full text